Back to today’s briefing

Story perspectives

RSV Hospitalizations Plummet Amid Breakthrough Vaccination Success

5/10/2025

32 5

Summary

Story summary

A recent CDC report reveals a remarkable decline in RSV hospitalizations among infants this winter, thanks to innovative vaccines and monoclonal antibodies. Additionally, the U.S. infant mortality rate has fallen to 5.5 deaths per 1,000 live births in 2024, reflecting the positive impact of vaccination efforts on infant health.

1 of 1

Story summary

A recent CDC report reveals a remarkable decline in RSV hospitalizations among infants this winter, thanks to innovative vaccines and monoclonal antibodies. Additionally, the U.S. infant mortality rate has fallen to 5.5 deaths per 1,000 live births in 2024, reflecting the positive impact of vaccination efforts on infant health.